Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder
AUTOR(ES)
Berlant, Jeffrey L
FONTE
BioMed Central
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=516778Documentos Relacionados
- Omega-3 fatty acids decreased irritability of patients with bipolar disorder in an add-on, open label study
- Paroxetine in Patients With Irritable Bowel Syndrome: A Pilot Open-Label Study
- Intermittent theta-burst transcranial magnetic stimulation for autism spectrum disorder: an open-label pilot study
- Duloxetine for the long-term treatment of Major Depressive Disorder in patients aged 65 and older: an open-label study
- Maintenance use of ketamine for treatment-resistant depression: an open-label pilot study